162 related articles for article (PubMed ID: 1714041)
1. Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs.
Johnston PA; Chahl LA
Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):283-8. PubMed ID: 1714041
[TBL] [Abstract][Full Text] [Related]
2. Locomotor activity and contracture of isolated ileum precipitated by naloxone following treatment of guinea-pigs with a single dose of morphine.
Chahl LA; Thornton CA
J Pharm Pharmacol; 1987 Jan; 39(1):52-4. PubMed ID: 2434641
[TBL] [Abstract][Full Text] [Related]
3. Effects of pertussis toxin on behavioural responses of guinea-pigs to centrally administered substance P, quinpirole, carbachol, U-50,488H, morphine and morphine withdrawal.
Bot G; Chahl LA
Eur J Pharmacol; 1993 Jan; 231(1):53-60. PubMed ID: 7680319
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists.
Michaud N; Couture R
Neuropeptides; 2003 Dec; 37(6):345-54. PubMed ID: 14698677
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.
Featherstone RL; Fosbraey P; Morton IK
Br J Pharmacol; 1986 Jan; 87(1):73-7. PubMed ID: 2420402
[TBL] [Abstract][Full Text] [Related]
6. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.
Kreeger JS; Larson AA
J Pharmacol Exp Ther; 1996 Nov; 279(2):662-7. PubMed ID: 8930169
[TBL] [Abstract][Full Text] [Related]
7. Enhancement by haloperidol of the locomotor response induced by naloxone in morphine-treated guinea pigs.
Chahl LA; Kavanagh CA; Corlis A
Neurosci Lett; 1989 Jan; 96(2):213-7. PubMed ID: 2927723
[TBL] [Abstract][Full Text] [Related]
8. The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs.
Brent PJ; Chahl LA; Cantarell PA; Kavanagh C
Eur J Pharmacol; 1993 Sep; 241(2-3):149-56. PubMed ID: 7902288
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with ascorbic acid inhibits the morphine withdrawal response in guinea-pigs.
Johnston PA; Chahl LA
Neurosci Lett; 1992 Jan; 135(1):23-7. PubMed ID: 1542433
[TBL] [Abstract][Full Text] [Related]
10. Effect of the nonpeptide NK-1 receptor antagonist CP-96,345 on the morphine withdrawal response of guinea-pigs.
Chahl LA; Johnston PA
Regul Pept; 1993 Jul; 46(1-2):373-5. PubMed ID: 7692540
[No Abstract] [Full Text] [Related]
11. Enhancement of the opiate withdrawal response by antipsychotic drugs in guinea-pigs is not mediated by sigma binding sites.
Brent PJ; Chahl LA
Eur Neuropsychopharmacol; 1993 Mar; 3(1):23-32. PubMed ID: 8097127
[TBL] [Abstract][Full Text] [Related]
12. Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal.
Zhou Q; Nyberg F
Neurosci Lett; 2002 Mar; 320(3):117-20. PubMed ID: 11852176
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
14. Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.
Piot O; Betschart J; Grall I; Ravard S; Garret C; Blanchard JC
Br J Pharmacol; 1995 Nov; 116(5):2496-502. PubMed ID: 8581290
[TBL] [Abstract][Full Text] [Related]
15. Naloxone-reversible effect of spantide on the spinally mediated behavioural response induced by neurokinin-2 and -3 receptor agonists.
Sakurada T; Manome Y; Katsumata K; Uchiumi H; Tan-No K; Sakurada S; Kisara K
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):69-75. PubMed ID: 1383832
[TBL] [Abstract][Full Text] [Related]
16. Substance P-(1-7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice.
Kreeger JS; Larson AA
Eur J Pharmacol; 1993 Jul; 238(1):111-5. PubMed ID: 7691618
[TBL] [Abstract][Full Text] [Related]
17. Studies on effects of the substance P analogues [D-Pro2, D-Trp7,9]-substance P and [D-Arg1, D-Trp7,9, L-Leu11]-substance P not related to their antagonist action.
Lembeck F; Amann R; Barthó L
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):290-3. PubMed ID: 2429194
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterisation of NK1 receptor antagonist, [D-Trp7]sendide, on behaviour elicited by substance P in the mouse.
Sakurada T; Yogo H; Manome Y; Tan-No K; Sakurada S; Yamada A; Kisara K; Ohba M
Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):387-92. PubMed ID: 7531295
[TBL] [Abstract][Full Text] [Related]
19. ICV administration of CRF blocker (CRF9-41 delta helical) reduces morphine withdrawal in rats.
Brugger S; Sánchez R; Brugger AJ; Martinez JA
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):775-85. PubMed ID: 9723119
[TBL] [Abstract][Full Text] [Related]
20. Distribution of c-Fos in guinea-pig brain following morphine withdrawal.
Chahl LA; Leah J; Herdegen T; Trueman L; Lynch-Frame AM
Brain Res; 1996 Apr; 717(1-2):127-34. PubMed ID: 8738262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
